Innovation Pharmaceuticals Inc (IPIX)

[djs7]

Pipeline A

1) Brilacidin ABSSSI Phase 2B

Pipeline B

There is now completed:

1) Brilacidin ABSSSI Phase 2B
2) Brilacidin UP Midstage (TOPLINE data Thursday)

To be completed 2017:

1) Brilacidin OM Phase 2 (Additional data Thursday)
2) Prurisol Phase 2B
(Interim analysis - any day now- targeting majority of patients with 6 weeks treatment May 10 PR around 70% enrolled, it's now 8 weeks later...is targeting majority of 6 weeks patients about 70-85% enrollment??)

Possible completion 2017:
1) Kevetrin Midstage Ovarian Cancer

Is the repetitive talk about no partner for Pipeline A infer no partnership from some or all drug indications in pipeline B??

Would you like them to cut a deal right now for just Brilacidin-ABSSSI??